Invention Grant
- Patent Title: Radiolabeled cannabinoid receptor 2 ligand
-
Application No.: US17125655Application Date: 2020-12-17
-
Publication No.: US11999710B2Publication Date: 2024-06-04
- Inventor: Simon M. Ametamey , Luca Gobbi , Uwe Grether , Julian Kretz , Dieter Muri , Ahmed Haider Wahauib
- Applicant: HOFFMANN-LA ROCHE INC. , ETH ZUERICH
- Applicant Address: US NJ Little Falls
- Assignee: HOFFMANN-LA ROCHE INC.,ETH ZUERICH
- Current Assignee: HOFFMANN-LA ROCHE INC.,ETH ZUERICH
- Current Assignee Address: US NJ Little Falls; CH Zurich
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Priority: EP 180154 2018.06.27
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07B59/00
Abstract:
The present invention relates to a compound of formula (I)
wherein R1, R2, and R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a radiolabeled ligand.
wherein R1, R2, and R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a radiolabeled ligand.
Public/Granted literature
- US20210115012A1 RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND Public/Granted day:2021-04-22
Information query
